UPDATED on 12/8/2025 Updated Overview: Synthetic Biology in Drug Discovery (December 2025 Edition)Aviva, your original 2016 post on PharmaceuticalIntelligence.com remains a visionary curation—focusing on synthetic biology’s (SynBio) potential to revolutionize drug discovery through engineered pathways, microbial factories, and novel therapeutics like PROTACs for galectins and CRISPR for genome editing. It highlighted LPBI’s mission to integrate … Continue reading Synthetic Biology in Drug Discovery